BIODISTRIBUTION OF A MONOCLONAL-ANTIBODY (RNL-1) AGAINST THE NEURAL CELL-ADHESION MOLECULE (NCAM) IN ATHYMIC MICE BEARING HUMAN SMALL-CELL LUNG-CANCER XENOGRAFTS

被引:15
作者
BOERMAN, OC
MIJNHEERE, EP
BROERS, JLV
VOOIJS, GP
RAMAEKERS, FCS
机构
[1] STATE UNIV LIMBURG, DEPT MOLEC CELL BIOL, POB 616, 6200 MD MAASTRICHT, NETHERLANDS
[2] UNIV HOSP NIJMEGEN, DEPT PATHOL, NIJMEGEN, NETHERLANDS
关键词
D O I
10.1002/ijc.2910480325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this investigation was to determine the targeting potential of the murine monoclonal antibody (MAb) RNL-1 for human small-cell lung cancer (SCLC) in a nude mouse model. RNL-1 is preferentially reactive with SCLC and lung carcinoids, and was classified as a cluster-1 MAb as defined by the international Workshop on Small-Cell Lung-Cancer Antigens. From the intercellular location of the target antigen and its reactivity with 3T3 cells transfected with nucleic acid sequences encoding for the neural cell adhesion molecule (NCAM), it was concluded that RNL-1 is directed against NCAM. RNL-1 was radiolabelled with either iodine-125 or indium-111 and injected into nude mice bearing NCl-H82 SCLC xenografts. The biodistribution of the radiolabels was determined up to 120 hr post injection. Maximum tumour accretion for In-111-RNL-l was 11.8%ID/g and 6.5%ID/g for I-125-RNL-1. The accumulation of In-111-RNL-1 could be visualized clearly by gamma scintigraphy without background subtraction techniques. Autoradiographs of whole-body sections from animals injected with I-125-RNL-1 showed that activity in the SCLC xenografts was mainly peripheral, suggesting that tumour uptake is dependent on the vascularization of the tumour tissue.
引用
收藏
页码:457 / 462
页数:6
相关论文
共 31 条
  • [1] ABO T, 1981, J IMMUNOL, V127, P1024
  • [2] A COMPARISON OF IODINE AND INDIUM LABELED ANTI CEA INTACT ANTIBODY, F(AB)2 AND FAB FRAGMENTS BY IMAGING TUMOR XENOGRAFTS
    ANDREW, SM
    PERKINS, AC
    PIMM, MV
    BALDWIN, RW
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 13 (11): : 598 - 604
  • [3] BERNAL SD, 1984, CANCER RES, V44, P265
  • [4] BEVERLY PCL, 1988, LUNG CANCER, V4, P15
  • [5] MONOCLONAL-ANTIBODIES THAT DISCRIMINATE BETWEEN HUMAN OVARIAN CARCINOMAS AND BENIGN OVARIAN-TUMORS
    BOERMAN, OC
    MAKKINK, WK
    THOMAS, CMG
    HANSELAAR, AGJM
    YEDEMA, CA
    KENEMANS, P
    POELS, LG
    [J]. EUROPEAN JOURNAL OF CANCER, 1990, 26 (02) : 117 - 127
  • [6] LABELING OF PROTEINS TO HIGH SPECIFIC RADIOACTIVITIES BY CONJUGATION TO A I-125-CONTAINING ACYLATING AGENT - APPLICATION TO RADIOIMMUNOASSAY
    BOLTON, AE
    HUNTER, WM
    [J]. BIOCHEMICAL JOURNAL, 1973, 133 (03) : 529 - 538
  • [7] BROERS JLV, 1986, J CELL SCI, V83, P37
  • [8] BROERS JLV, 1991, CANCER-AM CANCER SOC, V67, P619, DOI 10.1002/1097-0142(19910201)67:3<619::AID-CNCR2820670317>3.0.CO
  • [9] 2-Y
  • [10] BROWN BA, 1987, CANCER RES, V47, P1149